Frédéric Altare

Title: Frédéric Altare: Innovator in Immunology

Introduction

Frédéric Altare is a notable inventor based in Nantes, France. He has made significant contributions to the field of immunology, particularly in the diagnosis and treatment of diseases related to T lymphocytes. His innovative work has led to the development of a patent that addresses critical health issues.

Latest Patents

Frédéric Altare holds a patent that focuses on the diagnosis, prognosis, and treatment of diseases associated with a decrease in specific T lymphocytes. The invention outlines a method for determining the number, concentration, and proportion of T lymphocytes with a CD4CD8αα phenotype, which express CCR6 and/or CXCR6. This method is instrumental in diagnosing, prognosing outcomes, and predicting the risk of developing diseases, particularly inflammatory bowel diseases (IBD) such as Crohn's disease. The patent highlights the identification of two markers, CCR6 and CXCR6, which enable the selection of specific T lymphocyte populations from blood samples.

Career Highlights

Throughout his career, Frédéric Altare has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale (INSERM) and the Centre National de la Recherche Scientifique (CNRS). His work in these institutions has allowed him to advance his research and contribute to significant medical advancements.

Collaborations

Frédéric has collaborated with notable colleagues, including Guillaume Sarrabayrouse and Harry Sokol. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of immunology.

Conclusion

Frédéric Altare's contributions to immunology through his innovative patent and collaborations with leading research institutions underscore his impact on medical science. His work continues to pave the way for advancements in the diagnosis and treatment of critical health conditions.